Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 12:31:21 UTC |
---|
Update Date | 2021-09-26 23:07:07 UTC |
---|
HMDB ID | HMDB0253707 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Isovincamine |
---|
Description | methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate belongs to the class of organic compounds known as eburnan-type alkaloids. These are alkaloids with a structure based on the eburnan skeleton, that arises from rearrangement of the aspidospermidine ring system, involving migration of C-21 from C-7 to C-2, fission of the 2,16-bond, and attachment of C-16 to N-1. Based on a literature review very few articles have been published on methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate. This compound has been identified in human blood as reported by (PMID: 31557052 ). Isovincamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Isovincamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC12CCCN3CCC4=C(C13)N(C1=CC=CC=C41)C(O)(C2)C(=O)OC InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
Methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0,.0,.0,]nonadeca-2,4,6,8(18)-tetraene-17-carboxylic acid | Generator | Devincan | MeSH | Vincamine | MeSH | Vincapront | MeSH | Vincimax | MeSH | Cerebroxine | MeSH | Pervincamine | MeSH | Methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylic acid | Generator |
|
---|
Chemical Formula | C21H26N2O3 |
---|
Average Molecular Weight | 354.45 |
---|
Monoisotopic Molecular Weight | 354.194342705 |
---|
IUPAC Name | methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate |
---|
Traditional Name | vinca |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC12CCCN3CCC4=C(C13)N(C1=CC=CC=C41)C(O)(C2)C(=O)OC |
---|
InChI Identifier | InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3 |
---|
InChI Key | RXPRRQLKFXBCSJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as eburnan-type alkaloids. These are alkaloids with a structure based on the eburnan skeleton, that arises from rearrangement of the aspidospermidine ring system, involving migration of C-21 from C-7 to C-2, fission of the 2,16-bond, and attachment of C-16 to N-1. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Eburnan-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Eburnan-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Eburna alkaloid
- Indolo[3,2-1de][1,5]naphthyridine
- Beta-carboline
- Pyridoindole
- Diazanaphthalene
- Alpha-amino acid or derivatives
- Naphthyridine
- 3-alkylindole
- Indole
- Indole or derivatives
- Aralkylamine
- Piperidine
- Benzenoid
- Heteroaromatic compound
- Methyl ester
- Pyrrole
- Amino acid or derivatives
- Carboxylic acid ester
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organoheterocyclic compound
- Alkanolamine
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxygen compound
- Organooxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Isovincamine,1TMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C)(C(=O)OC)C2 | 2834.5 | Semi standard non polar | 33892256 | Isovincamine,1TMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C)(C(=O)OC)C2 | 2843.1 | Standard non polar | 33892256 | Isovincamine,1TMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C)(C(=O)OC)C2 | 3869.7 | Standard polar | 33892256 | Isovincamine,1TBDMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C(C)(C)C)(C(=O)OC)C2 | 3069.3 | Semi standard non polar | 33892256 | Isovincamine,1TBDMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C(C)(C)C)(C(=O)OC)C2 | 3131.6 | Standard non polar | 33892256 | Isovincamine,1TBDMS,isomer #1 | CCC12CCCN3CCC4=C(C31)N(C1=CC=CC=C41)C(O[Si](C)(C)C(C)(C)C)(C(=O)OC)C2 | 3959.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Isovincamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-014i-1092000000-3dd2d28125ef8525c0f2 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovincamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovincamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovincamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0009000000-c8a93f63fd326a4849c6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 10V, Positive-QTOF | splash10-0a4i-0009000000-f84ad34715d7f60a130e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0016-0295000000-62a6c1949341db26f60f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0029000000-bf4915152d29a3e508e5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0016-0294000000-c091a2ad270fddbea87f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0i03-0490000000-6a1ea8eb14ef9bf903ac | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0009000000-10c391668bbe89c5c44b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0019000000-893cfb0b4af48911825b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0i03-0490000000-d09140f16ef166a8664f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-07vl-0490000000-bd0a525d1ca0fabd01a3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0016-0294000000-aa9cb2aaa662744befbe | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0029000000-e93a0f15eade930901d8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovincamine 6V, Positive-QTOF | splash10-0a4i-0009000000-11e645ab043b0fc308d7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 10V, Positive-QTOF | splash10-0a4i-0009000000-47937e1bca34335c6cdb | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 20V, Positive-QTOF | splash10-0a4i-0009000000-e9be33e13362b7beed20 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 40V, Positive-QTOF | splash10-0k96-2779000000-4ef0c11c23488f14e14b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 10V, Negative-QTOF | splash10-00di-0009000000-7ff99e50e367d90be940 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 20V, Negative-QTOF | splash10-0udj-0069000000-f8f9ff287c883c7d56e5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovincamine 40V, Negative-QTOF | splash10-0v04-0090000000-a46c9d4c71e4355d04b2 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|